Sevredol and dehydration Patient Reports February 13, 2012
Sevredol Side Effects Report #5637303-9
Sevredol side effect was reported by a Health Professional from FRANCE on Feb 13, 2008. Female patient, 72 years of age, was diagnosed with pain
and was treated with Sevredol. After drug was administered, patient experienced the following side effects: dehydration, hyperuricaemia, hypochloraemia, vomiting. Sevredol dosage: 10 MG, DAILY. During the same period patient was treated with METFORMIN, RILMENIDINE, LESCOL, ACTRAPID MC, AMLOR, ZESTORETIC, VALIUM, KARDEGIC. Patient was hospitalized. Patient recovered.Sevredol Side Effects Report #5648716-3
Sevredol side effect was reported by a Health Professional from FRANCE on Feb 26, 2008. Female patient, 72 years of age, was diagnosed with pain
and was treated with Sevredol. After drug was administered, patient experienced the following side effects: blood urea increased, dehydration, hypochloraemia, renal failure, vomiting. Sevredol dosage: 10 MG, DAILY. During the same period patient was treated with METFORMIN, RILMENIDINE, LESCOL, ACTRAPID MC, AMLOR, ZESTORETIC, VALIUM, KARDEGIC. Patient was hospitalized. Patient recovered.Sevredol Side Effects Report #5709238-4
Sevredol side effect was reported by a Health Professional from FRANCE on Apr 10, 2008. Female patient, 72 years of age, was diagnosed with pain
and was treated with Sevredol. After drug was administered, patient experienced the following side effects: blood urea increased, dehydration, hypochloraemia, renal failure, vomiting. Sevredol dosage: 10 MG, DAILY. During the same period patient was treated with METFORMIN, RILMENIDINE, LESCOL, ACTRAPID MC, AMLOR, ZESTORETIC, VALIUM, KARDEGIC. Patient was hospitalized. Patient recovered.Sevredol Side Effects Report #4771005-6
Sevredol side effect was reported by a Health Professional from FRANCE on Aug 29, 2005. Male patient, 57 years of age, was diagnosed with pain
and was treated with Sevredol. After drug was administered, patient experienced the following side effects: abnormal behaviour, c-reactive protein increased, confusional state, dehydration, haemoglobin decreased, lung disorder, oxygen saturation decreased, platelet count decreased, tachycardia. Sevredol dosage: 60 MG, DAILY, ORAL. During the same period patient was treated with DURAGESIC, ESOMEPRAZOLE, DULPHALAC, FOLIC ACID, DICLOFENAC, VALIUM, NEURONTIN. Patient was hospitalized. Patient recovered.
Sevredol and dehydration 